cTAP Abstract for 2019 NORD Summit

August 2019 cTAP abstract entitled "Pioneering collaborative analytics to accelerate therapy approval and access in rare disease" for the 2019 NORD Summit. View the Full PDF

2019 WMS Abstract – 48-Week Changes in NSAA

Consistency of 48-week changes in North Star Ambulatory Assessment (NSAA) between Duchenne muscular dystrophy (DMD) natural history data and clinical trial placebo arms, after adjustment for prognostic factors View the Full PDF